 | SVB Leerink Lowers Adaptimmune Therapeutics (NASDAQ:ADAP) Price Target to $10.00
marketbeat.com - August 6 at 11:19 AM |
 | Adaptimmune Therapeutics PLC (ADAP) Q2 2020 Earnings Call Transcript
nasdaq.com - August 6 at 11:02 PM |
 | SVB Leerink Cuts Adaptimmune Therapeutics (NASDAQ:ADAP) Price Target to $10.00
americanbankingnews.com - August 6 at 11:15 AM |
 | Adaptimmune Reports Q2 Financial Results and Business Update
finance.yahoo.com - August 6 at 8:00 AM |
| Adaptimmune Therapeutics PLC - (NASDAQ:ADAP) Insider Sells $44,612.75 in Stock
americanbankingnews.com - August 5 at 5:28 AM |
| Adaptimmune Therapeutics (ADAP) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - July 30 at 4:05 AM |
| Adaptimmune Therapeutics PLC - (NASDAQ:ADAP) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - July 28 at 3:38 AM |
| Adaptimmune Therapeutics (NASDAQ:ADAP) Stock Price Down 6.2%
www.americanbankingnews.com - July 23 at 7:44 PM |
 | Adaptimmune's ADP-A2M4 nabs accelerated review in EU for soft tissue cancer
seekingalpha.com - July 23 at 7:43 PM |
| Adaptimmune Granted Access to PRIority MEdicines (PRIME) Regulatory Support by the European Medicines Agency for ADP-A2M4 for the Treatment of Synovial Sarcoma
finance.yahoo.com - July 23 at 7:43 PM |
|
| Adaptimmune to Report Q2 Financial Results and Business Update on Thursday, August 6, 2020
finance.yahoo.com - July 22 at 9:34 AM |
| $950,000.00 in Sales Expected for Adaptimmune Therapeutics PLC - (NASDAQ:ADAP) This Quarter
www.americanbankingnews.com - July 21 at 3:58 AM |
| Adaptimmune Therapeutics (NASDAQ:ADAP) Trading Up 5.3%
www.americanbankingnews.com - July 20 at 7:46 PM |
| Adaptimmune Therapeutics PLC - (NASDAQ:ADAP) Expected to Announce Earnings of -$0.24 Per Share
www.americanbankingnews.com - July 19 at 6:42 AM |
| Should You Buy Adaptimmune Therapeutics plc (ADAP)?
finance.yahoo.com - July 5 at 5:33 PM |
| First Week of August 21st Options Trading For Adaptimmune Therapeutics (ADAP)
www.nasdaq.com - June 29 at 3:01 PM |
| How Adaptimmune Therapeutics (ADAP) Stock Stands Out in a Strong Industry
www.nasdaq.com - June 17 at 12:19 PM |
| Is Adaptimmune Therapeutics a Buy?
finance.yahoo.com - June 12 at 8:05 AM |
 | Wayne biopharm firm raises $20M to advance lead drug candidate
www.bizjournals.com - June 10 at 1:09 PM |
| Why Adaptimmune Therapeutics Stock Crushed It in May
finance.yahoo.com - June 8 at 1:27 PM |
 | Affinia Therapeutics Announces Appointment of Elliott Sigal, M.D., Ph.D. to the Company's Board of Directors
www.marketwatch.com - June 8 at 8:26 AM |
| Adaptimmune prices ADS offering at $11
seekingalpha.com - June 2 at 7:59 AM |
| Are Options Traders Betting on a Big Move in Adaptimmune Therapeutics (ADAP) Stock?
finance.yahoo.com - June 2 at 7:59 AM |
| Adaptimmune Announces $11/ADS Pricing; Stock Now Up Over 850% YTD
finance.yahoo.com - June 2 at 7:59 AM |
 | BRIEF-Adaptimmune Therapeutics PLC Prices Public Offering Of American Depositary Shares
www.reuters.com - June 2 at 12:56 AM |
| Party Time: Brokers Just Made Major Increases To Their Adaptimmune Therapeutics plc (NASDAQ:ADAP) Earnings Forecasts
finance.yahoo.com - June 1 at 2:54 PM |
| Why Adaptimmune Therapeutics Stock Sank and Then Quickly Rebounded Today
finance.yahoo.com - June 1 at 2:54 PM |
| Adaptimmune readies ADS offering
seekingalpha.com - June 1 at 9:26 AM |
| Adaptimmune's stock tumbles after plans for public stock offering
finance.yahoo.com - June 1 at 9:26 AM |
| Adaptimmune Spikes 127% Post-ASCO; Analyst Triples Price Target
finance.yahoo.com - June 1 at 4:26 AM |
|
| Here's Why Adaptimmune Therapeutics Is Rocketing Higher Today
finance.yahoo.com - May 29 at 5:32 PM |
| The Dow Slipped 18 Points Because Trump Pulled His Punches on China
finance.yahoo.com - May 29 at 5:32 PM |
 | Adaptimmune Therapeutics Makes a Big Splash at ASCO
www.msn.com - May 29 at 12:32 PM |
 | Thinking about buying stock in Adaptimmune Therapeutics, MEI Pharma, Dynavax Technologies, AIM ImmunoTech, or Meridian Bioscience?
www.prnewswire.com - May 29 at 12:32 PM |
| SPEAR T-cells Targeting MAGE-A4 Demonstrate New Responses in Esophagogastric Junction (EGJ), Lung, and Head and Neck Cancers – Late Stage Development Initiated in EGJ Cancer
finance.yahoo.com - May 29 at 12:31 PM |
| Adaptimmune Stock Doubles on Positive Cancer Drug Data
finance.yahoo.com - May 29 at 12:31 PM |
| Traders Sift Through Virtual Cancer Meeting’s Winners and Losers
finance.yahoo.com - May 29 at 12:31 PM |
| Where Will Adaptimmune Be in 5 Years?
finance.yahoo.com - May 19 at 8:04 AM |
| Edited Transcript of ADAP earnings conference call or presentation 14-May-20 12:00pm GMT
finance.yahoo.com - May 15 at 9:53 AM |
| Cancer Gene Therapy Market Size Outlook 2020 to 2025: Market Trends, Segmentation, Growth Rate and Competitive Landscape with COVID-19 Outbreak
www.marketwatch.com - May 15 at 4:52 AM |
| Adaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 5:38 PM |
| Thinking about buying stock in Adaptimmune Therapeutics, Upwork, Eldorado Resorts, Co-Diagnostics, or Delta Air Lines?
www.marketwatch.com - May 14 at 12:38 PM |
| Region set to add thousands of new cell and gene therapy jobs in decade ahead, study says
www.bizjournals.com - May 14 at 12:38 PM |
| Adaptimmune Reports Q1 Financial Results
finance.yahoo.com - May 14 at 12:38 PM |
| Recap: Adaptimmune Therapeutics Q1 Earnings
finance.yahoo.com - May 14 at 12:38 PM |
| Adaptimmune Therapeutics PLC (ADAP) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 14 at 12:38 PM |
| SPEAR T-cells Derived from Stem-Cells Kill Cancer Targets - Adaptimmune Presents Advances from its Allogeneic Platform at ASGCT Annual Meeting
finance.yahoo.com - May 12 at 8:34 AM |
| BRIEF-Adaptimmune Therapeutics To Rely On SEC Order To Delay Filing Of Its Quarterly Report On Form 10-Q
www.reuters.com - April 29 at 1:58 PM |
| Adaptimmune to Report Q1 Financial Results on Thursday, May 14, 2020
finance.yahoo.com - April 29 at 8:58 AM |
| Adaptimmune's ADP-A2M4 an Orphan Drug in Europe for soft tissue cancer
seekingalpha.com - April 28 at 12:55 PM |
| BRIEF-EMA Committee for Orphan Medicinal Products adopts positive opinion for Orphan Drug Designation for ADP-A2M4 -Adaptimmune Therapeutics
www.reuters.com - April 28 at 12:55 PM |
